Votes: LA HB403 | 2023 | Regular Session
Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Voting Records
| Chamber | Vote | Date | Yea | Nay | NV | Abs | Total | Result | Source | View |
|---|---|---|---|---|---|---|---|---|---|---|
| Senate | Senate Vote on HB 403 FINAL PASSAGE (#540) | 2023-05-29 | 39 | 0 | 0 | 0 | 39 | Passed | Link | View |
| House | House Vote on HB 403 FINAL PASSAGE (#359) | 2023-05-11 | 92 | 0 | 0 | 13 | 105 | Passed | Link | View |
